Sofer, Yael

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial

Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., Lingvay, I., Mosenzon, O., Rosenstock, J., Rubio, M. A., et al. (2021) · JAMA

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 1,444

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.

Del Prato, S., Kahn, S. E., Pavo, I., Weerakkody, G. J., Yang, Z., Doupis, J., Aizenberg, D., Wynne, A. G., Riesmeyer, J. S., Heine, R. J., et al. (2021) · The Lancet

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 684

Increment in Dietary Potassium Predicts Weight Loss in the Treatment of the Metabolic Syndrome

Tal, B., Sack, J., Yaron, M., Shefer, G., Buch, A., Ben Haim, L., Marcus, Y., Shenkerman, G., Sofer, Y., Shefer, L., et al. (2019) · Nutrients

Nutritional Studies and DietDiet and metabolism studies

Cited by 17

Human sex hormone-binding globulin does not provide metabolic protection against diet-induced obesity and dysglycemia in mice

Sofer, Y., Nevo, N., Vechoropoulos, M., Shefer, G., Osher, E., Landis, N., Tordjman, K., Hammond, G. L., & Stern, N. (2018) · Endocrine Connections

Adipokines, Inflammation, and Metabolic DiseasesHormonal and reproductive studies

Cited by 6